Icon

PRILOSEC (nda019810)- (10MG,20MG,40MG)

OMEPRAZOLE ASTRAZENECA
10MG,20MG,40MG
Yes No
2019-May-10 Expired
None None
None No
PRILOSEC is a proton pump inhibitor (PPI) indicated for the: • Treatment of active duodenal ulcer in adults • Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults • Treatment of active benign gastric ulcer in adults • Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older • Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older • Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older • Pathologic hypersecretory conditions in adults
15 1 11
Total Other Developers None
Drugs with Suitability No
10MG ** ** - - 7
20MG ** ** - 9 -
40MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
No 8
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ****** ***** ************ ******* *********** (***), **** **. ***-*, *********** ****** **** ****, ********** ****, ****** *****, *********, ********* ******, ***** (***) ***
****** ****** ****** ***. *********** *** ****** *****, *******, ******* *** ***, ****** (***) ***
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** & ***, ******* ***** ******** ******* ** * *, *******-*******, ***-******, ****. - *********, *********, ******* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-*, ******* ********** ******, *******-******,, ***, ** ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ******* ************ ******* *** *********** ******** ********** ********** *, ******** ** *******, *****, ***** (***) ***
****** ******* ************ ******* *** *********** ******* ** ********** *, ****** ** *******, ******** ** ******* *****, ***** (***) ***
****** ****** *** *.*. *********** ********** ***** **, *********, - ****, ******** (***) ***
****** ************ **** ************** ******, *.*. *********** ***** ** **** *****, **-**, ***********, *****, ***** (***) ***
****** ****** *** *.*. *********** ********** ***** **, *********, - ****, ******** (***) ***
****** ************ ************ **************, ***. *********** ** ******** *****, ***** ***, ******, *********** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.